AlphaFold predicted structure
IL17RD · Q8NFM7

Mean pLDDT
68.3/ 100
Low
739 residues
Confidence breakdown
- Very high(≥ 90)34%
- Confident(70–90)23%
- Low(50–70)7%
- Very low(< 50)37%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
interleukin 17 receptor D
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Hypogonadotropic hypogonadism
BIALLELIC, autosomal or pseudoautosomalHypogonadotropic hypogonadism (GMS)
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
UnknownKallmann syndrome
hypogonadotropic hypogonadism 18 with or without anosmia
Abnormality of the skeletal system
Delayed puberty
neurodegenerative disease
chronic obstructive pulmonary disease
Cerebral arteriovenous malformation
asthma
placenta praevia
hypogonadotropic hypogonadism
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interleukin-17 receptor D
Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation (PubMed:12807873, PubMed:12958313). Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK (PubMed:15239952). Mediates JNK activation and may be involved in apoptosis (By similarity). May inhibit FGF-induced FGFR1 tyrosine phosphorylation (By similarity). Might have a role in the early stages of fate specification of GnRH-secreting neurons (By similarity). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (By similarity)
IL17RD · Q8NFM7

Mean pLDDT
68.3/ 100
Low
739 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0